Mehdi Cheniti
| Mehdi Cheniti | |
|---|---|
| Born | April 18, 1948 Norway |
| 🏳️ Nationality | Norwegian |
| 🎓 Alma mater | University of Tunis El Manar |
| 💼 Occupation | |
| Known for | Oncology |
Mehdi Cheniti (born 18 April 1948) is a Norwegian/Algerian physician specialising in oncology, who has published numerous research articles.[1]
Mehdi is known for having made a breakthrough discovery in the field of bronchopneumopathy[2], and has between 1970 and 1972 contributed to treating 39 patients with rifampicin[3]
He is currently undertaking courses in informatics at the University of Oslo.[4]
References
- ↑ "Cheniti M". National Center for Biotechnology Information. Retrieved 1 March 2021.
- ↑ "Obstructive chronic bronchopneumopathy with localized bronchial starting point", National Library of Medicine
- ↑ "Results of treatment with rifampicin in 39 patients hospitalized in our service during 1970-1971-1972", National Library of Medicine
- ↑ "University of Oslo · Department of Informatics", ResearchGate
This article "Mehdi Cheniti" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Mehdi Cheniti. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
